Zobrazeno 1 - 10
of 266
pro vyhledávání: '"Cantilena, S"'
Autor:
Cantilena S; Hemispherian AS, 0585 Oslo, Norway.; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London WC1N 1EH, UK., AlAmeri M; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London WC1N 1EH, UK.; Department of Health-Abu Dhabi, Abu Dhabi 20224, United Arab Emirates., Che N; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London WC1N 1EH, UK., Williams O; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London WC1N 1EH, UK., de Boer J; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London WC1N 1EH, UK.; Australian & New Zealand Children's Haematology/Oncology Group, Melbourne, VIC 3052, Australia.; Australia & Hudson Institute of Medical Research, Melbourne, VIC 3168, Australia.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Nov 29; Vol. 16 (23). Date of Electronic Publication: 2024 Nov 29.
Autor:
Che N; Cancer Section, Developmental Biology and Cancer Department, UCL Great Ormond Street Institute of Child Health, London, UK., Cantilena S; Cancer Section, Developmental Biology and Cancer Department, UCL Great Ormond Street Institute of Child Health, London, UK., Looi-Somoye R; Cancer Section, Developmental Biology and Cancer Department, UCL Great Ormond Street Institute of Child Health, London, UK., Sundar D; Cancer Section, Developmental Biology and Cancer Department, UCL Great Ormond Street Institute of Child Health, London, UK., Fung K; Department of Haematology, UCL Cancer Institute, London, UK., de Boer J; Cancer Section, Developmental Biology and Cancer Department, UCL Great Ormond Street Institute of Child Health, London, UK. j.boer@ucl.ac.uk., Williams O; Cancer Section, Developmental Biology and Cancer Department, UCL Great Ormond Street Institute of Child Health, London, UK. owen.williams@ucl.ac.uk.
Publikováno v:
Experimental hematology & oncology [Exp Hematol Oncol] 2024 Aug 16; Vol. 13 (1), pp. 84. Date of Electronic Publication: 2024 Aug 16.
Autor:
Karsa M; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia., Xiao L; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia., Ronca E; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia., Bongers A; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia., Spurling D; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia., Karsa A; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia., Cantilena S; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London, UK., Mariana A; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.; ACRF Drug Discovery Centre for Childhood Cancer, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia., Failes TW; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia.; ACRF Drug Discovery Centre for Childhood Cancer, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia., Arndt GM; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia.; ACRF Drug Discovery Centre for Childhood Cancer, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia., Cheung LC; Leukemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia.; Curtin Medical School, Curtin University, Perth, WA, Australia.; Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia., Kotecha RS; Leukemia Translational Research Laboratory, Telethon Kids Cancer Centre, Telethon Kids Institute, Perth, WA, Australia.; Curtin Medical School, Curtin University, Perth, WA, Australia.; Department of Clinical Haematology, Oncology, Blood and Marrow Transplantation, Perth Children's Hospital, Perth, WA, Australia.; Division of Paediatrics, School of Medicine, University of Western Australia, Perth, WA, Australia., Sutton R; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia., Lock RB; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia.; UNSW Centre for Childhood Cancer Research, UNSW Sydney, Sydney, Australia., Williams O; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London, UK., de Boer J; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London, UK., Haber M; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia., Norris MD; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia.; UNSW Centre for Childhood Cancer Research, UNSW Sydney, Sydney, Australia., Henderson MJ; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia., Somers K; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, NSW, Australia. ksomers@ccia.org.au.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia. ksomers@ccia.org.au.
Publikováno v:
Journal of molecular medicine (Berlin, Germany) [J Mol Med (Berl)] 2024 Apr; Vol. 102 (4), pp. 507-519. Date of Electronic Publication: 2024 Feb 13.
Autor:
Bueno C; Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain.; Spanish Collaborative Cancer Network, Carlos III Health Institute, Barcelona, Spain., Torres-Ruiz R; Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain., Velasco-Hernandez T; Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain., Molina O; Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain., Petazzi P; Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain., Martinez A; Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain., Rodriguez V; Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain., Vinyoles M; Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain., Cantilena S; Development Biology Cancer Program, Cancer Section, UCLGOS Institute of Child Health, London, United Kingdom., Williams O; Development Biology Cancer Program, Cancer Section, UCLGOS Institute of Child Health, London, United Kingdom., Vega-Garcia N; Hematology Laboratory, Hospital Sant Joan de Déu Barcelona, Barcelona, Spain.; Developmental Tumors Biology Group, Leukemia, and other Pediatric Hemopathies, Pediatric Cancer Center Barcelona, Institut de Recerca, Hospital Sant Joan de Déu, Barcelona, Spain., Rodriguez-Perales S; Molecular Cytogenetics and Genome Editing Unit, Human Cancer Genetics Program, Centro Nacional de Investigaciones Oncologicas, Madrid, Spain., Segovia JC; Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain., Quintana-Bustamante O; Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, Madrid, Spain.; Advanced Therapies Unit, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain., Roy A; MRC Molecular Hematology Unit, MRC Weatherall Institute of Molecular Medicine, Oxford Biomedical Research Center Hematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom.; Department of Pediatrics and National Institute for Health and Care Research Oxford Biomedical Research Centre Hematology Theme, University of Oxford, Oxford, United Kingdom., Meyer C; Diagnostic Center of Acute Leukemia-Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany., Marschalek R; Diagnostic Center of Acute Leukemia-Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany., Smith AL; MRC Molecular Hematology Unit, MRC Weatherall Institute of Molecular Medicine, Oxford Biomedical Research Center Hematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Milne TA; MRC Molecular Hematology Unit, MRC Weatherall Institute of Molecular Medicine, Oxford Biomedical Research Center Hematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom., Fraga MF; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; Cancer Epigenetics and Nanomedicine Laboratory, Nanomaterials and Nanotechnology Research Center, El Entrego, Spain.; Health Research Institute of Asturias, Institute of Oncology of Asturias and Department of Organisms and Systems Biology, University of Oviedo, Oviedo, Spain., Tejedor JR; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; Cancer Epigenetics and Nanomedicine Laboratory, Nanomaterials and Nanotechnology Research Center, El Entrego, Spain.; Health Research Institute of Asturias, Institute of Oncology of Asturias and Department of Organisms and Systems Biology, University of Oviedo, Oviedo, Spain., Menéndez P; Stem Cell Biology, Immunotherapy and Developmental Leukemia Laboratory. Josep Carreras Leukemia Research Institute, Barcelona, Spain.; Spanish Network for Advanced Therapies, Carlos III Health Institute, Barcelona, Spain.; Spanish Collaborative Cancer Network, Carlos III Health Institute, Barcelona, Spain.; Department of Biomedicine, University of Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
Publikováno v:
Blood [Blood] 2023 Nov 16; Vol. 142 (20), pp. 1752-1756.
Autor:
Cantilena S; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London, UK., Gasparoli L; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London, UK., Pal D; Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK., Heidenreich O; Newcastle Cancer Centre at the Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK., Klusmann JH; Department of Pediatrics I, Martin-Luther-University Halle-Wittenberg, Halle, Germany., Martens JHA; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Radboud University, Nijmegen, The Netherlands., Faille A; Cambridge Institute for Medical Research, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK., Warren AJ; Cambridge Institute for Medical Research, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Wellcome Trust-Medical Research Council Stem Cell Institute, University of Cambridge, Cambridge, UK., Karsa M; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, New South Wales, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, New South Wales, Australia., Pandher R; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, New South Wales, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, New South Wales, Australia., Somers K; Children's Cancer Institute, Lowy Cancer Research Institute, University of New South Wales, Randwick, New South Wales, Australia.; School of Women's and Children's Health, University of New South Wales, Randwick, New South Wales, Australia., Williams O; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London, UK., de Boer J; Cancer Section, Development Biology and Cancer Programme, UCL GOS Institute of Child Health, London, UK.
Publikováno v:
Clinical and translational medicine [Clin Transl Med] 2022 Jun; Vol. 12 (6), pp. e933.
Autor:
Clesham K; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK.; University College London Hospital, London, UK., Walf-Vorderwülbecke V; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Gasparoli L; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Virely C; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Cantilena S; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Tsakaneli A; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Inglott S; SIHMDS-Haematology, Great Ormond Street Hospital for Children, London, UK., Adams S; SIHMDS-Haematology, Great Ormond Street Hospital for Children, London, UK., Samarasinghe S; Department of Paediatric Haematology, Great Ormond Street Hospital for Children, London, UK., Bartram J; Department of Paediatric Haematology, Great Ormond Street Hospital for Children, London, UK., Williams G; Wolfson Centre for Age-Related Diseases, King's College London, London, UK., de Boer J; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Williams O; Cancer Section, Developmental Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK. owen.williams@ucl.ac.uk.
Publikováno v:
Leukemia [Leukemia] 2022 Jun; Vol. 36 (6), pp. 1541-1549. Date of Electronic Publication: 2022 Apr 02.
Autor:
Meier S; Cancer Section, Development Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Cantilena S; Cancer Section, Development Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Niklison Chirou MV; Centre for Therapeutic Innovation, Department of Pharmacy & Pharmacology, University of Bath, Bath, UK., Anderson J; Cancer Section, Development Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Hargrave D; Cancer Section, Development Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK., Salomoni P; Nuclear Function in CNS Pathophysiology, German Center for Neurodegenerative Diseases, Bonn, Germany., de Boer J; Cancer Section, Development Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK. j.boer@ucl.ac.uk., Michod D; Cancer Section, Development Biology and Cancer Programme, UCL Great Ormond Street Institute of Child Health, London, UK. d.michod@ucl.ac.uk.
Publikováno v:
Cell death & disease [Cell Death Dis] 2021 Aug 11; Vol. 12 (8), pp. 785. Date of Electronic Publication: 2021 Aug 11.
Autor:
Corvetta, D, Chayka, O, Gherardi, S, D'Acunto, CW, Cantilena, S, Valli, E, Piotrowska, I, Perini, G, Sala, A
Publikováno v:
The Journal of Biological Chemistry
Background: The neuroblastoma oncogene MYCN and the PRC2 members EZH2 and SUZ12 are regulators of gene transcription. Results: MYCN and PRC2 form a repressive complex on the promoter of the tumor suppressor gene CLU. Conclusion: PRC2 members are recr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2334388974883ba96b15a7851a5f6c29
http://hdl.handle.net/11585/191779
http://hdl.handle.net/11585/191779
Autor:
Guo, Xiaojuan1 (AUTHOR), Huang, Guinian1 (AUTHOR), Qiu, Dafa1 (AUTHOR), He, Huiqing1 (AUTHOR), Niu, Xiaomin1 (AUTHOR), Guo, Ziwen1 (AUTHOR) zsgzw@21cn.com, Ye, Yongbin1 (AUTHOR) zsyongbiny1984@163.com
Publikováno v:
BMC Cancer. 9/27/2024, Vol. 24 Issue 1, p1-13. 13p.
Autor:
Mao, Chenkai1,2 (AUTHOR) cmao@mcw.edu, Poimenidou, Maria2 (AUTHOR), Craig, Brian T.1,2 (AUTHOR) bcraig@mcw.edu
Publikováno v:
Cancers. Aug2024, Vol. 16 Issue 16, p2865. 24p.